Pharmaceutical Venture Capital Firms
Welcome to VC Firms List, where we specialize in providing quality lists of venture capital firms across different industries. Today, we are focusing on an increasingly vital sector in the investment world: pharmaceutical venture capital firms. As the pharmaceutical industry continues its rapid growth, venture capitalist support plays a vital role in fostering innovation and development. Did you know, according to a report by Statista, global venture financing in biotech companies reached over $16 billion in 2020, indicating the market's enormous potential.
Read more
Company:
1315 Capital
Description: 1315 Capital is a distinguished entity in the realm of venture capital and private equity, specializing in providing expansion and growth capital to commercial-stage companies in the healthcare sector. This includes investment in healthcare services, medical technology, pharmaceutical outsourcing, and health and wellness enterprises. The firm recognizes the inherent attractiveness of these investment areas, which are characterized by numerous niche market subsegments and innovative business models. This landscape allows high-quality management teams to effectively scale small platform companies into significant and influential businesses in a capital-efficient manner.
The firm strategically targets investments ranging from $10 million to $40 million in commercial healthcare entities that demonstrate the potential to evolve into approximately $100 million in revenue. This revenue benchmark is viewed as highly appealing for either acquisition opportunities or access to public markets, enhancing the prospects for sustainable growth.
In addition to its seasoned investing partners, 1315 Capital employs an effective operating partner model, which includes a CEO and a Right Hand COO Executive. This collaborative partnership is designed to navigate due diligence processes, drive critical decisions, and work diligently towards achieving premium exits. The firm benefits from the collective experience of three dedicated operating teams specializing in medical technologies, healthcare services, and specialty therapeutics. Collectively, these teams have successfully transformed companies from their expansion and growth phases to entities boasting revenues exceeding $100 million, culminating in an impressive aggregate exit value of nearly $5 billion. Through this robust approach and commitment to operational excellence, 1315 Capital is well-positioned to continue making substantial contributions to the healthcare investment landscape.
Industry: Venture Capital and Private Equity
Founded: 2014
Domain: http://www.1315capital.com/
Location: Philadelphia, PA
Address: 2929 Walnut Street, Suite 1240, Philadelphia, PA 19104, US
Size: 11-50 employees
Company:
5AM Ventures
Description: 5AM Ventures, established in 2002, is a prominent venture capital and private equity firm specializing in investments within the realm of advanced life science innovations. The firm emphasizes a diverse portfolio that spans both biopharmaceutical therapeutics and various platform technologies. Within these sectors, 5AM Ventures strategically allocates its investments across a wide array of therapeutic areas and modalities, allowing for a comprehensive approach to identifying and evaluating promising opportunities.
The firm's investment strategy is particularly focused on innovative platform technologies, corporate spinoffs, and products characterized by shorter development cycles. This methodical evaluation process ensures that 5AM Ventures identifies ventures that exhibit high potential within the rapidly evolving landscape of life sciences.
It is important to note that the content shared by 5AM Ventures is provided solely for informational purposes and should not be interpreted as legal, tax, investment, accounting, or similar advice. Furthermore, it does not constitute an offer to sell or a solicitation of an offer to buy interests in any private fund, special purpose vehicle, or other investment vehicle sponsored by 5AM Ventures. For a comprehensive overview of all the companies within the 5AM portfolio, interested parties are encouraged to visit their official website at https://5amventures.com/portfolio.
Industry: Venture Capital and Private Equity
Founded: 2002
Domain: http://www.5amventures.com/
Location: San Francisco, California
Address: 501 2nd St, San Francisco, California 94107, US
Size: 11-50 employees
Company:
ARCHIMED
Description: ARCHIMED is a prominent investment firm with a distinct focus on the healthcare sector, operating from offices strategically located across Europe, North America, and the Asia-Pacific region. The firm's unique combination of operational, medical, scientific, and financial expertise positions ARCHIMED as both a strategic and financial partner for businesses within the healthcare industry.
ARCHIMED prioritizes several key areas, which include Biopharma Products, Consumer Health, Healthcare Information Technology, In Vitro Diagnostics, Life Science Tools, Biologic Services, Medical Technology (MedTech), and Pharma Services. By concentrating on these sectors, ARCHIMED assists its partners in internationalizing their operations, acquiring new opportunities, innovating effectively, and expanding their product and service offerings.
The firm manages a substantial asset portfolio, totaling €7 billion across its various investment funds. Notably, ARCHIMED operates the largest healthcare-only private equity fund that has been raised by a General Partner based in Europe. Since its inception, ARCHIMED has demonstrated a commitment to impact investing, both directly and through initiatives associated with its EURKA Foundation, reinforcing its dedication to fostering positive change within the healthcare landscape. Through its strategic investments and partnerships, ARCHIMED continues to play a vital role in advancing healthcare innovation and improving outcomes in the industry.
Industry: Venture Capital and Private Equity
Founded: 2014
Domain: http://www.archimed.group/
Location: Lyon, Auvergne-Rhone-Alpes
Address: 9 rue des Cuirassiers, Lyon, Auvergne-Rhone-Alpes 69003, FR
Size: 51-200 employees
Company:
Arc Ventures
Description: Arc Ventures is a prominent venture capital firm based in New York City. The firm is dedicated to identifying and investing in opportunities across various stages of a company’s life cycle, ranging from early-stage, pre-revenue ventures to more developed, later-stage operating businesses. With a strong focus on transformative potential, Arc Ventures actively seeks to invest in disruptive technologies that have the capacity to reshape industries, as well as innovative pharmaceutical solutions that can enhance healthcare delivery and outcomes. Through its strategic investments, the firm aims to foster growth and innovation in these dynamic sectors.
Industry: Venture Capital and Private Equity
LinkedIn: https://www.linkedin.com/company/arc-vc
Domain: http://www.arc-vc.com/
Location: New York
Address: New York, US
Size: 2-10 employees
Company:
Argentum Capital Partners
Description: Argentum Capital Partners is a growth equity firm based in New York that specializes in partnering with founders and entrepreneurs to develop industry-leading B2B software and technology-enabled business services companies. The firm focuses on investing in companies that have annual revenues ranging from $3 million to $25 million, offering capital to support their growth objectives, fund acquisitions, and facilitate shareholder liquidity.
With a rich history spanning over three decades, Argentum has successfully invested in 90 companies and has provided support for 200 add-on acquisitions. The firm occupies a unique position in the investment landscape, filling the increasing gap between early-stage venture capital and later-stage growth equity. Argentum specifically targets bootstrapped companies seeking equity capital in the range of $3 million to $15 million, primarily aiming for minority ownership stakes.
Argentum's investment expertise covers a diverse array of sectors, including but not limited to software, technology-enabled services, software as a service (SaaS), cloud-based platforms, enterprise software, financial technology, regulatory technology and compliance, human capital management, B2B e-commerce and logistics, as well as various applications within both vertical and horizontal markets. Their focus also extends to healthcare and pharmaceutical services, clinical research organizations, healthcare IT, healthcare data analytics and intelligence, business services, specialty staffing and workforce solutions, transportation logistics, regulatory compliance services, transaction processing, and specialty distribution.
The firm has well-defined investment criteria, seeking companies with revenues between $3 million and $25 million, and focuses on growth equity recapitalizations. Investment sizes typically range from $5 million to $15 million for minority ownership stakes, although Argentum is also capable of accommodating majority stakes or buyouts when appropriate.
In terms of geographic focus, Argentum primarily invests in U.S.-based companies that exhibit an attractive growth profile and strategy, possess strong, committed leadership, and maintain a recurring revenue stream. Their ideal investments feature a proven and scalable business model that operates within a highly fragmented industry, establishing meaningful barriers to entry and competitive advantages.
For any inquiries regarding prospective investment opportunities or add-on acquisitions involving portfolio companies, interested parties are encouraged to reach out to Chris Leong at chris@argentumgroup.com or Jean Parker at jean@argentumgroup.com.
Industry: Venture Capital and Private Equity
Founded: 1988
Domain: http://www.argentumgroup.com/
Location: New York, NY
Address: 17 State St, New York, NY 10004, US
Size: 11-50 employees
Company:
Boston Millennia Partners
Description: Boston Millennia Partners is a reputable firm specializing in private equity financing targeted at high-growth companies within the healthcare and life sciences sectors. With a wealth of experience and an extensive skill set, the firm seamlessly integrates finance, operations, engineering, and life sciences research and development. This diverse expertise enables Boston Millennia Partners to build valuable partnerships with pharmaceutical companies and provide essential support in business development, executive recruiting, and legal matters.
Since its inception in the early 1980s, the team at Boston Millennia Partners has successfully managed venture capital partnerships, achieving impressive results for both their investors and the entrepreneurs they support. The continued growth and success of their portfolio companies have provided a solid foundation for Boston Millennia Partners, allowing them to expand their capital base to over $700 million in assets under management. Their commitment to nurturing innovation and fostering the development of cutting-edge companies positions Boston Millennia Partners as a significant player in the venture capital and private equity landscape.
Industry: Venture Capital and Private Equity
Founded: 1984
Location: Boston, MA
Address: 30 Rowes Wharf, Boston, MA 02110, US
Size: 2-10 employees
Company:
California Technology Ventures
Description: California Technology Ventures is an early-stage venture capital firm that concentrates its efforts primarily on two key sectors: Information and Communications Technology (ICT) and Life Sciences. Within the ICT domain, the firm focuses on a range of innovations such as computer hardware, telecommunications, software, semiconductors, and Internet technologies. In the Life Sciences sector, California Technology Ventures invests in advancements including biopharmaceuticals and medical devices.
The core mission of California Technology Ventures is to cultivate the growth of world-class companies by offering essential capital resources and strategic guidance to motivated entrepreneurs and their teams. The firm prides itself on partnering with promising startups that demonstrate passion and innovation, ensuring they have the support necessary to achieve their goals.
Among the notable investments made by California Technology Ventures are companies such as AngioScore, Aivita Biomedical, InSound Medical Inc., MariaDB, Orthoscan Inc., and Travelmuse Inc., showcasing a diverse portfolio that reflects their commitment to advancing technology and health solutions. Typical investment amounts range from $250,000 to $2 million, allowing the firm to engage effectively at various stages of a startup's development.
For entrepreneurs seeking financial backing, California Technology Ventures offers a proprietary deal entry system, MyDealVC.com, where they can create a personal profile to submit their projects, including attachments and updates. This streamlined process facilitates efficient communication and ensures that the firm remains accessible to innovative companies looking for investment opportunities. Any inquiries can be directed to the firm via their contact email at info@ctventures.com.
Industry: Venture Capital and Private Equity
Domain: http://www.ctventures.com/
Location: Pasadena, CA
Address: 670 N. Rosemead Blvd., Suite 201, Pasadena, CA 91107, US
Size: 2-10 employees
Company:
Catalys Pacific
Description: Catalys Pacific is a prominent venture capital and private equity firm based in Japan, distinguished by its focus on the life sciences sector. Capitalizing on its extensive networks within academia, the biotechnology arena, venture capital, and the pharmaceutical industry, Catalys Pacific has successfully formed a collaborative group of Strategic and Preferred Partners. This strategic approach enables the firm to develop asset-centric global bioventure companies that are dedicated to advancing innovative solutions.
As one of the largest investment firms in Japan concentrated on life sciences, Catalys Pacific is committed to addressing unmet medical needs faced by patients around the world. The firm's mission revolves around the creation and investment in companies that drive impactful innovation within the life sciences industry. Furthermore, Catalys Pacific is dedicated to maintaining a strictly independent governance structure, which allows for autonomous assessment and decision-making regarding its investments. This commitment to independence ensures that Catalys Pacific can effectively pursue its goal of fostering groundbreaking advancements in the health sector.
Industry: Venture Capital and Private Equity
Domain: http://www.catalyspacific.com/
Location: Minato-ku, Tokyo
Address: 8-14, Minami-Aoyama 3-chome, AUSPICE OMOTESANDO 4F, Minato-ku, Tokyo 107-0062, JP
Size: 2-10 employees
Company:
Curewell Capital
Description: Curewell Capital is a dynamic investment firm dedicated to fostering the growth of industry-leading healthcare companies. With a strong emphasis on innovation and improvement in patient outcomes, the firm leverages its extensive decades of investment and operational experience in various sectors, including healthcare services, medical devices, life sciences, and pharmaceutical services.
Curewell Capital collaborates closely with owners and management teams of exceptional companies, striving to drive advancements that not only enhance patient care but also reduce costs within the healthcare landscape. The firm boasts a diverse patient capital base, which enables it to invest strategically in both minority and majority equity positions. This flexibility in its investment approach is complemented by an adaptable time horizon, allowing for a tailored strategy that aligns with the unique needs of each partnership.
Headquartered in Los Angeles, California, Curewell Capital is well-positioned to make a significant impact in the healthcare investment sector, working diligently to support companies that are at the forefront of innovation and transformation within the industry.
Industry: Venture Capital and Private Equity
Domain: http://www.curewellcapital.com/
Location: Los Angeles, CA
Address: Los Angeles, CA, US
Size: 2-10 employees
Company:
DEFTA Partners
Description: DEFTA Partners, founded in 1985 in California, is a distinguished player in the venture capital and private equity sector. The firm has made a significant impact in identifying, investing in, and nurturing startups and individuals who are at the forefront of developing innovative technologies. Primarily focused on markets in Japan, the United States, and Europe, DEFTA Partners leverages its extensive experience and established expertise to foster growth in these regions.
With a strong international presence, DEFTA Partners has successfully expanded its operations beyond its California headquarters by establishing additional offices in Japan and Hong Kong. This strategic positioning allows the firm to maintain a broad network and gain valuable insights into emerging markets.
The firm is particularly keen on discovering promising early-stage companies within the biotechnology, pharmaceutical, and healthcare sectors. By providing the necessary support and resources, DEFTA Partners aims to fuel their growth trajectories and empower them to scale their businesses on a global level.
Industry: Venture Capital and Private Equity
Founded: 1985
Domain: http://www.deftapartners.com/
Location: San Francisco
Address: San Francisco, US
Size: 2-10 employees
Company:
Deep Science Ventures
Description: Deep Science Ventures is a pioneering venture creator that integrates existing scientific knowledge with innovative scientists who possess a founder's mindset. The organization's mission is to establish high-impact ventures that contribute to a sustainable future for both humanity and the planet. Deep Science Ventures operates across four key sectors: Pharmaceuticals, Climate, Agriculture, and Computation. In each of these domains, the company addresses critical challenges by employing a first principles approach, which allows for a deep understanding of the underlying issues at hand. This method is complemented by strategic partnerships with leading institutions, enhancing their capacity to drive meaningful change. For more detailed information about their initiatives and projects, interested parties are encouraged to visit their website.
Industry: Venture Capital and Private Equity
Founded: 2016
Location: London
Address: London, GB
Size: 11-50 employees
Company:
ExSight Ventures
Description: ExSight Ventures is a distinguished venture capital firm that focuses on early-stage impact investments specifically aimed at innovative solutions in ophthalmic diagnostics and treatments. The firm is comprised of two accomplished retinal surgeons who bring their extensive medical expertise to the investment process, working alongside a dedicated team of investment professionals. Together, they have partnered to meet the growing demand for funding in early-stage companies that concentrate on ophthalmic advancements.
ExSight Ventures seeks to invest in a variety of fields, including biotechnology, medical devices, pharmaceuticals, and software solutions tailored to the ophthalmology sector. With their unique combination of medical knowledge and investment acumen, the firm is well-positioned to identify and support pioneering companies that are poised to make significant contributions to the field of eye care. For those interested in contacting ExSight Ventures for potential collaboration or inquiries, further details can be found on their official website.
Industry: Venture Capital and Private Equity
Founded: 2014
Domain: http://www.exsightventures.com/
Location: New York
Address: 1460 Broadway, New York, US
Size: 2-10 employees
Company:
F-Prime Capital
Description: F-Prime Capital is a distinguished entity in the realms of venture capital and private equity, tracing its origins to the storied legacy of Fidelity Investments. Founded in 1946, Fidelity began as a single mutual fund and has since evolved into one of the largest asset management firms globally, boasting over $2 trillion in assets under management.
For the past four decades, F-Prime Capital has established itself as a key player in the venture capital landscape, devoted to supporting dynamic entrepreneurs as they innovate and develop transformative companies primarily within the technology and life sciences sectors. The firm's impressive portfolio showcases its commitment to groundbreaking ventures, having backed notable names such as Atari, MCI, ROLM Corporation, Alibaba, Ironwood Pharmaceuticals, and Ultragenyx.
Today, while F-Prime Capital's funds have expanded and taken on a more global scope, the firm continues to maintain a focus on small, localized teams. This structure allows them to stay true to their entrepreneurial roots. In the United States and Europe, the team operates under the name F-Prime Capital, where they specialize in investments in healthcare, previously known as Fidelity Biosciences, and in technology, which was formerly a part of Devonshire Investors. In various other regions, their sister fund operates as Eight Roads, previously referred to as Fidelity Growth Partners, with dedicated investment teams situated in major cities such as London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai.
Through their extensive network and valuable industry insights, F-Prime Capital is committed to leveraging domain expertise to nurture and empower entrepreneurs. By alleviating the pressures typically associated with fundraising from external investors, the firm dedicates its efforts entirely to identifying and collaborating with outstanding entrepreneurs, ultimately working together to build important companies that can shape the future.
Industry: Venture Capital and Private Equity
Domain: http://www.fprimecapital.com/
Location: Cambridge, MA
Address: One Main Street, Cambridge, MA 02142, US
Size: 11-50 employees
Company:
FountainVest
Description: FountainVest stands as one of the most prominent independent private equity firms in Asia, distinguished by its robust management of capital sourced from some of the world’s largest and most established institutions. The firm concentrates its investments on both industry leaders and emerging market players that exhibit a strong track record of high growth. FountainVest has earned a stellar reputation in the market for its innovative and pioneering transactions, including its involvement in one of China’s first leveraged buyouts (LBOs) during the privatization of Focus Media.
The firm’s diverse portfolio features notable companies such as IMAX, Peacebird, Key Safety Systems, Meituan Dianping, Zhaopin, Trendy, WME IMG, China Guazi, Lao Bai Xing, Pure Fitness, Amer Sports, Rokin Logistics, Langdi Pharmaceutical, and Ziwi Pet Food. FountainVest adopts a highly focused, sector-based investment strategy, which facilitates the development of deep expertise within specific subsectors. This approach not only creates sector-specific ecosystems but also leverages the firm's outstanding market reputation, networks, and extensive know-how, all garnered over more than a decade as an independent institutional private equity firm.
An essential aspect of FountainVest’s investment philosophy is its commitment to a hands-on approach, enhancing the value creation process within its portfolio companies through the capabilities of its operational team and advisory platforms. The firm boasts an impressive track record as a cycle-tested manager that consistently delivers strong performance and liquidity across various market cycles. Its operational framework incorporates clear, systematic, and institutional processes that significantly strengthen its risk management capabilities.
Furthermore, FountainVest places considerable importance on environmental, social, and corporate governance (ESG) criteria in its investment practices. This commitment underscores the firm’s dedication to not only financial performance but also to cultivating champions in the marketplace while adhering to sustainable and responsible investment principles.
Industry: Venture Capital and Private Equity
Founded: 2007
Domain: http://www.fountainvest.com/
Location: Hong Kong SAR
Address: Two International Finance Centre, 8 Finance Street, Central, Hong Kong SAR, HK
Size: 51-200 employees